Human DR4 antibodies and uses thereof

Details for Australian Patent Application No. 2008260311 (hide)

Owner Genentech, Inc.

Inventors Kim, Kyung Jin; Chuntharapai, Anan

Agent Griffith Hack

Pub. Number AU-A-2008260311

Parent 2002366430

Filing date 18 December 2008

Wipo publication date 15 January 2009

International Classifications

C12N 15/02 (2006.01) Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 5/18 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Murine cells, e.g. mouse cells

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

8 January 2009 Complete Application Filed

15 January 2009 Application Open to Public Inspection

  Published as AU-A-2008260311

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008260326-Cyclic peptide CXCR4 antagonists

2008260310-Split-stream processing methods and systems for multi-phase food products